Singapore (9 Nov, 2020) – Topcon Healthcare Solutions Asia Pacific, the leading Japanese ophthalmic solution provider, has inked an agreement with Singapore based EyRIS Private Limited to bring EyRIS SELENA+ to Harmony’s users in 18 countries in South and South East Asia. SELENA+ is a deep learning system (DLS) that can detect 3 eye diseases – diabetic retinopathy, glaucoma suspect and age-related macular degeneration. Harmony is an Eye Health Screening solution developed by Topcon Healthcare Solutions that enables screening sites to be linked with eye professionals in a seamless and efficient manner.

Topcon is reputed in the industry for their high-performance retinal imaging cameras and is one of the leading manufacturers in the world. They are a leading innovator in the eye screening field from both hardware and software that are widely accepted in both the private and public sectors.

EyRIS’s award winning artificial intelligence, SELENA+, was jointly developed by the Singapore Eye Research Institute (SERI) and National University of Singapore – School of Computing (NUS-SoC). SELENA+ is able to detect the retinal diseases in less than 2 minutes upon submission of the patient’s fundus images.

“We are deeply humbled by Topcon’s decision to partnering EyRIS. It is an affirmation of confidence in our product and the team of clinicians & technology researchers behind the product. We look forward to a fruitful working relationship with Topcon in the years to come.” said Mr. Lai Teik Kin, the CEO of EyRIS.

Mr. Leo Hiroshi Nagatake, Managing Director of Topcon Healthcare Solution Asia Pacific also added “Topcon is extremely excited to be able to work with EyRIS in Asian countries. We firmly believe this collaboration will bring the current situation of eye health to the next stage by having our innovative products put together.”

With the changing diet and lifestyle, the prevalence of diabetes is growing at an alarming rate in Asia. Consequently, there is a correlated rise in diabetic related blindness which can be prevented through early detection and treatment. This collaboration underlines the synergies that can be harnessed to pursue a shared vision of creating awareness of the importance for annual screening and making quality eyecare more accessible to all.


Please direct all queries related to this article to Marketing at enquiry@nova-hub.com

Comments are closed.